From September,1st 2020 COFEPRIS establishes the request for appointments will be via the internet and face-to-face attention in the CIS for the entry of priority formalities.
COFEPRIS establishes operating rules to promote the production of generic drugs in Mexico, by eliminating criteria that limited their production and their availability at more accessible prices for the population.
Cosmetics is a dynamic industry, with new novel products ready to market it puts significant pressure on companies to understand global regulation and registration processes in order to reach consumers and markets globally.
PMDA has adapted emerging technologies such as AI based medical devices and has reviewed the registration process to make it more efficient.
On October 2019, Anvisa published its formal regulations for custom-made medical devices “RDC 305/2019. “
Anvisa announces its regulatory priorities for Medical Devices in 2020.